EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Adaptive Rewiring of Nucleotide Metabolism in Therapeutic Resistance

Bengisu Dayanc, Ganfei Xu iD, Xiaoshu Zhou, Jinpeng Chen, Noah Mueller, Harsimran Kaur, Breanna Pham, Satoshi Yoda iD, Jaime L Schneider iD

Cancers · 30.10.2026 · 18 (21) · 3498

DOI: 10.3390/cancers18213498 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.10.2026. Verfasst von Bengisu Dayanc und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Die Arbeit nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lung Cancer Research Foundation, International Association for the Study of Lung Cancer, Gilead Sciences (France).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic resistance remains a major barrier to durable cancer control and is increasingly recognized as a dynamic process shaped not only by genetic evolution but also by metabolic adaptation. Nucleotide metabolism is uniquely positioned at this interface, supporting DNA and RNA synthesis while also regulating signaling, energy homeostasis, redox balance, genome maintenance, and cellular stress responses. In this Review, we examine emerging evidence that cancer cells in solid tumors adapt nucleotide metabolism in response to therapeutic pressure through coordinated remodeling of de novo biosynthesis, nucleotide salvage, metabolite transport, and pathway-specific feedback mechanisms. We discuss how cytotoxic chemotherapy, targeted therapies, immunotherapies, and radiation impose distinct but convergent pressures on nucleotide homeostasis and how restoration or redistribution of nucleotide pools can promote survival, DNA repair, persistent oncogenic signaling, and immune evasion. We further highlight the reciprocal relationship between oncogenic signaling and nucleotide metabolism, as well as the contribution of tumor suppressor loss and the tumor microenvironment to context-specific metabolic dependencies. Rather than functioning only as a biosynthetic requirement of proliferating cells, nucleotide metabolism emerges as a flexible stress-response network that can facilitate adaptation to cancer therapy. Defining the mechanisms that maintain nucleotide balance in resistant tumors may reveal therapeutically actionable dependencies and inform rational combination strategies designed to prevent or overcome treatment resistance.

Schlagwörter

Stichwörter der Autor:innen

acquired therapeutic resistanceimmunotherapy resistancemetabolic reprogrammingnucleotide metabolismtargeted therapy resistance

Autor:innen und Institutionen

  • Department of Medical Oncology, Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Key Laboratory of Chinese Medicine Resource and Compound Prescription, Ministry of Education, Hubei University of Chinese Medicine, Wuhan 430065, China.
  • Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

ORCID-Profile: Ganfei Xu, Satoshi Yoda, Jaime L Schneider

Förderung

  • Lung Cancer Research Foundation
  • International Association for the Study of Lung Cancer
  • Gilead Sciences (France)
  • The ROS1ders Foundation
  • Lung Cancer Foundation of America
  • The ROS1ders, Inc.

Zitieren

APA

Dayanc, B., Xu, G., Zhou, X., Chen, J., Mueller, N., Kaur, H., Pham, B., Yoda, S., & Schneider, J. L. (2026). Adaptive Rewiring of Nucleotide Metabolism in Therapeutic Resistance. Cancers, 18(21), 3498. https://doi.org/10.3390/cancers18213498

Vancouver

Dayanc B, Xu G, Zhou X, Chen J, Mueller N, Kaur H, et al. Adaptive Rewiring of Nucleotide Metabolism in Therapeutic Resistance. Cancers. 2026;18(21):3498. doi:10.3390/cancers18213498

BibTeX
@article{Dayanc2026,
  author = {Dayanc, Bengisu and Xu, Ganfei and Zhou, Xiaoshu and Chen, Jinpeng and Mueller, Noah and Kaur, Harsimran and Pham, Breanna and Yoda, Satoshi and Schneider, Jaime L},
  title = {Adaptive Rewiring of Nucleotide Metabolism in Therapeutic Resistance},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {21},
  pages = {3498},
  doi = {10.3390/cancers18213498}
}
Kostenlos starten →